RTI Biologics Announces Distribution and Supply Agreement with Aesculap for Biocleanse-Sterilized Spinal Allografts

ALACHUA, Fla.–(BUSINESS WIRE)–RTI Biologics, Inc. (RTI) (Nasdaq:RTIX – News), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, announced today that it has signed an agreement to provide spinal allograft implants to Aesculap Implant Systems, Inc.

Under the agreement, which is effective immediately, RTI will process cervical and lumbar spinal grafts from designs developed by Aesculap Implant Systems.

“We are pleased to work with Aesculap Implant Systems to deliver more sterilized spinal implants to surgeons,” said Brian K. Hutchison, RTI’s chairman and chief executive officer. “Through our agreement, we will be able to help even more patients with biologic solutions in spinal surgeries.”